Navigation Links
Kepner-Tregoe (KT) Announces 2012 International Process Achievement Award Recipients
Date:3/21/2013

PRINCETON, N.J., March 21, 2013 /PRNewswire-iReach/ -- Kepner-Tregoe (KT), the global capability development and consulting company, today announced the results of its annual International Process Achievement Awards—a recognition of the best use of rational process—or Clear Thinking—from companies around the world.  Gold, silver and bronze awards were given in two categories: single/team use and organizational deployment.

(Photo: http://photos.prnewswire.com/prnh/20130320/CG81039)

2012 winners are:

Organizational Deployment

Gold: Griffin's Foods
Silver: Tellabs
Bronze: Johnson Controls

Single and Team Use

Gold: Bobrick Washroom Equipment
Silver: CSL Behring
Bronze: Honeywell

Entries for the 2012 International Process Achievement Awards were judged based on several criteria including cost savings, demonstrated problem solving, decision-making abilities and others.  Winners showed an ability and willingness to implement critical thinking processes as a standard part of its operations process. 

"Everyone at Kepner-Tregoe congratulates these outstanding teams and organizations for implementing Clear Thinking and working to transform their processes to materially affect outcomes," said Ray Baxter , Kepner-Tregoe's chief executive officer.  "It is inspiring to see the hard work and hundreds of hours that these teams have taken to integrate transformative thinking into their organizations.  KT is privileged to work with firms that believe in the power of Clear Thinking as much as we do."

First developed and awarded in 1995, the KT International Process Achievement Award has a long history of highlighting organizations that have used rational process to make decisions under the constraints imposed by today's breakneck business environment. The 2012 recipients include several multi-year winners including Griffin's Foods and Johnson Controls. 

About Kepner-Tregoe Inc.

Kepner-Tregoe (KT) provides capability development and consulting solutions across the world to help build Thinking Organizations that resolve the most pressing issues with clarity and confidence. Founded in 1958 based on ground-breaking research on how people think, solve problems and make decisions, Princeton-based Kepner-Tregoe is dedicated to helping organizations achieve Operational Excellence by improving quality, increasing efficiency and reducing costs. KT Clear Thinking is used at every level of client organizations: to implement strategy; achieve step-change improvements in operations; increase customer satisfaction in support organizations; and drive superior issue resolution throughout the organization. KT provides Clear Thinking for a complex world. For additional information, visit the company's website at kepner-tregoe.com or their social media platforms on LinkedIn, Twitter, Facebook and YouTube.

Media Contact:

Brad Russell Pierpont Communications, 210-372-9200, brussell@piercom.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Kepner-Tregoe
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. DKMS Americas announces new branding initiative to increase donor registry numbers
2. Fuisz llc Announces Induction of Richard C. Fuisz, M.D., into Georgetown Universitys 1789 Society.
3. Ohr Pharmaceutical Announces Results from OHR/AVR118 Phase II Trial in Cancer Cachexia
4. Elbit Imaging Announces Receipt of an Acceleration Notice from Bank Leumi
5. Hologic Announces Completion of Loan Repricing
6. Meridian Health Plan Announces New Pharmacy Benefit Manager
7. GS Medical USA announces FY2012 record year-end sales growth of over 130% over FY2011
8. ENCO Pharmaceutical Development Announces Another Successful FDA Inspection - Its 2nd This Year
9. Research and Markets Announces the Release of Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities
10. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
11. EGEN, Inc. Announces a Phase I Clinical Trial for Advanced Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... http://www.rebound-solution.com/ ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
Breaking Medicine News(10 mins):